Here are seven recent news updates on key gastroenterology and endoscopy companies.
The FDA has approved Epigenomics' Epi proColon, making it the first and only FDA-approved blood-based colorectal cancer screening test.
The FDA's Gastrointestinal Drugs Advisory Committee voted unanimously to recommend accelerated approval of Intercept Pharmaceuticals' Ocaliva.
LifeBond received the CE Mark for its LifeSeal Surgical Sealant.
NanoAntibiotics acquired LAT Pharma, early-stage biotechnology company developing medicines to treat life-threatening complications of liver cirrhosis.
Bank of Montreal Can increased its stake in EndoChoice by 25.5 percent.
Boston Scientific's SpyGlass DS Direct Visualization System was acquired by the Digestive Disease Centre of UCT Private Academic Hospital in Cape Town, South Africa.
Gilead Sciences presented data in a conference supporting the development of three investigational agents for the treatment of nonalcoholic steatohepatitis and primary sclerosing cholangitis.